Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Advirna
company
About
Advirna is a Biotechnology Company.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $150K
- Industries
- Biotechnology
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Advirna’s self-deliverable RNAi is based on the recent breakthrough in biology known as RNA interference (RNAi). This discovery opened a possibility to specifically regulate activity of genes inside a living cell.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$150K
Advirna has raised a total of
$150K
in funding over 2 rounds. Their latest funding was raised on
May 20, 2014 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 20, 2014 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Advirna is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
